PHILADELPHIA -- Screening for prostate cancer with a PSA (prostate specific antigen) blood test, though routinely performed today in men middle-aged and older, remains a source of controversy. Questions continue about the test's overall effectiveness and its ability to actually save men's lives.
For example, elevated PSA levels don't necessarily equate with clinically significant prostate cancer. Some men faced with high test results, however, may have undergone unnecessary treatments, with debilitating side effects such as infertility, incontinence and impotence.
For others, a normal PSA has also be misleading. In these cases, undetected prostate cancer has grown and spread to other parts of the body, sometimes resulting in death.
Nevertheless, if caught early, men have a 100 percent, five-year survival rate a surprisingly positive statistic compared to many other types of cancer. Clearly, early detection is a key to curing prostate cancer.
To put this controversy in perspective, a forum on "Controversies in the Screening and Early Detection of Prostate Cancer, will be held on Sunday, April 17, Room 204 Anaheim Convention Center at the 96th Annual Meeting of the American Association for Cancer Research.
The forum will feature two outspoken authorities in the field:
Otis W. Brawley, M.D., professor of Medicine, Hematology and Oncology at the Emory University School of Medicine and Professor of Epidemiology at the Emory Rollins School of Public Health, Atlanta, Ga.
Fritz H. Schroder, professor and chair of the Department of Urology, Erasmus University, Rotterdam, The Netherlands.
The session will be moderated by:
William G. Nelson V, M.D., Ph.D., professor in the departments of Oncology, Urology, Pharmacology and Molecular Sciences, Medicine, Pathology, and Radiation Oncology and Molecular Radiation Sciences, at Johns Hopkins University.
Members of the press are cordially invited
Contact: Warren R. Froelich
American Association for Cancer Research 7-Apr-2005Page: 1 2 Related medicine news :1
. Researchers suggest TB screening for all international adoptees2
. Osteoporosis screening and treatment may be cost-effective for selected older men3
. Syphilis screening, lithium fights neurodegeneration, monoclonal antibodies against avian flu4
. Advances in screening and markers improve early detection of colorectal cancer5
. GI screening: Racing time or wasting time?6
. Routine HIV screening in the ED is cost effective and well liked by patients7
. Simple screening can help decrease teen risk behaviors8
. Johns Hopkins begins aggressive screening for superbugs in children9
. Study recommends universal newborn screening for cystic fibrosis10
. Opportunistic chlamydia screening not underpinned by sound evidence11
. New guideline for screening mammography for women 40 to 49 years of age